Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium phage-type DT104 among salmonellae causing enteritis in Israel.
The relative frequency of salmonella strains isolated from hospitalized and non-hospitalized patients in Southern Israel changed during the period, 1994-6. Salmonella enterica serotype Typhimurium definitive phage-type 104 (DT104) appeared in Israel in 1994 and became the most prevalent strain in 1996. An outbreak of enteritis due to Salmonella enterica serotype Agona occurred in Israel, in October 1994 and lasted for 4 months. The relative frequency of Salmonella enterica serotype Enteritidis remained almost constant during these years, with seasonal fluctuations only. The importance of the increase in the prevalence of Typhimurium DT104 has been the epidemic spread of a multiresistant strain of R-type ACT (A, ampicillin; C, chloramphenicol; T, tetracycline) belonging to this phage-type. Since 1995 the frequency of Typhimurium DT104 isolates that possess, in addition to the above R-type, a chromosomally encoded resistance to the quinolone drug, nalidixic acid, increased tenfold. In 1996, 27% of the Typhimurium DT104 isolates were of R-type ACTN. S. Enteritidis exhibited over 95% susceptibility to at least eight of the most commonly used antibiotic drugs, and none of the isolates was resistant to quinolone or fluoroquinoline.
Metzer
E
E
Department of Molecular Virology, The Faculty of Medicine, Hebrew University of Jerusalem.
Agmon
V
V
Andoren
N
N
Cohen
D
D
D001434:Bacteriophage Typing; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004751:Enteritis / Q000382:microbiology*; D006801:Humans; D007557:Israel; D008826:Microbial Sensitivity Tests; D019779:Salmonella enterica / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D012703:Serotyping; D013997:Time Factors